RecallRadar

FDA Device recall Z-1682-2018

IMMULITE ¿ /IMMULITE ¿ 1000 OM-MA (CA125)

On 2018-05-16 the FDA classified a Class II recall of IMMULITE ¿ /IMMULITE ¿ 1000 OM-MA (CA125) by Siemens Healthcare Diagnostics, citing concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Siro….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1682-2018
ClassificationClass II
Statusterminated
Initiated2018-01-02
Published2018-05-16
Last updated2026-09-13 11:54 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

IMMULITE ¿ /IMMULITE ¿ 1000 OM-MA (CA125)

Reason

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

Identifiers

code_infoOM-MA (CA125), OM-MA (CA125) (IMMULITE/IMMULITE 1000, LKOP1), (IMMULITE 2000/IMMULITE 2000 XPi, LKOP2) Lot codes: CA125 (OM-MA) 0211 0212 0213

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1682-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.